Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 79 articles: HTML format Text format

Single Articles

January 2012
1. VAN TURENHOUT ST , Terhaar Sive Droste JS, Meijer GA, Masclee AA, et al
   Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand.
   BMC Cancer. 2012;12:46.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. GARCIA-BILBAO A , Armananzas R, Ispizua Z, Calvo B, et al
   Identification of a biomarker panel for colorectal cancer diagnosis.
   BMC Cancer. 2012;12:43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. LANG AH , Geller-Rhomberg S, Winder T, Stark N, et al
   A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.
   BMC Cancer. 2012;12:20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. FAHMUELLER YN , Nagel D, Hoffmann RT, Tatsch K, et al
   Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy.
   BMC Cancer. 2012;12:5.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
5. RAWLUSZKO AA , Horbacka K, Krokowicz P, Jagodzinski PP, et al
   Decreased expression of 17-beta-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon.
   BMC Cancer. 2011;11:522.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. NEUMANN J , Bahr F, Horst D, Kriegl L, et al
   SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer.
   BMC Cancer. 2011;11:518.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. MUINELO ROMAY L , Villar Portela S, Cuevas E, Gil Martin E, et al
   Identification of alpha(1,6)fucosylated Proteins Differentially Expressed in Human Colorectal Cancer.
   BMC Cancer. 2011;11:508.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
8. DAHAN L , Norguet E, Etienne-Grimaldi MC, Formento JL, et al
   Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer.
   BMC Cancer. 2011;11:496.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. ZHOU JJ , Li J, Ying XJ, Song YM, et al
   Fast Track Multi-Discipline Treatment (FTMDT trial) Versus Conventional Treatment In Colorectal Cancer - The Design of A Prospective Randomized Controlled Study.
   BMC Cancer. 2011;11:494.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. HASHIMOTO Y , Skacel M, Lavery IC, Mukherjee AL, et al
    Correction: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
    BMC Cancer. 2011;11:488.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
11. ENROTH S , Rada-Iglesias A, Andersson R, Wallerman O, et al
    Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosa.
    BMC Cancer. 2011;11:450.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. BIRGISSON H , Wallin U, Holmberg L, Glimelius B, et al
    Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival.
    BMC Cancer. 2011;11:438.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GROSSMANN I , Klaase JM, Avenarius JK, de Hingh IH, et al
    The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer.
    BMC Cancer. 2011;11:433.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. NEKLASON DW , Done MW, Sargent NR, Schwartz AG, et al
    Activating mutation in MET oncogene in familial colorectal cancer.
    BMC Cancer. 2011;11:424.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
15. REISSFELDER C , Timke C, Schmitz-Winnenthal H, Rahbari NN, et al
    A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer.
    BMC Cancer. 2011;11:419.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. QIU HB , Chen G, Keshari RP, Luo HY, et al
    The extramural metastasis might be categorized in lymph node staging for colorectal cancer.
    BMC Cancer. 2011;11:414.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. RAMOS M , Llagostera M, Esteva M, Cabeza E, et al
    Knowledge and attitudes of primary healthcare patients regarding population-based screening for colorectal cancer.
    BMC Cancer. 2011;11:408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BOEHMER U , Ozonoff A, Miao X
    An ecological analysis of colorectal cancer incidence and mortality: Differences by sexual orientation.
    BMC Cancer. 2011;11:400.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
19. WILF MIRON R , Peled R, Yaari E, Vainer A, et al
    The association between socio-demographic characteristics and adherence to breast and colorectal cancer screening: Analysis of large sub populations.
    BMC Cancer. 2011;11:376.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHINTHARLAPALLI S , Papineni S, Lei P, Pathi S, et al
    Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
    BMC Cancer. 2011;11:371.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. GIESSEN C , Fischer von Weikersthal L, Hinke A, Stintzing S, et al
    A Randomized, Phase III Trial of Capecitabine plus Bevacizumab (Cape-Bev) versus Capecitabine plus Irinotecan plus Bevacizumab (CAPIRI-Bev) in First-Line Treatment of Metastatic Colorectal Cancer: The AIO KRK 0110 Trial / ML22011 Trial.
    BMC Cancer. 2011;11:367.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. POWER E , Simon A, Juszczyk D, Hiom S, et al
    Assessing awareness of colorectal cancer symptoms: Measure development and results from a population survey in the UK.
    BMC Cancer. 2011;11:366.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ZAFAR SY , Malin JL, Grambow SC, Abbott DH, et al
    Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study.
    BMC Cancer. 2011;11:354.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. STRATMANN J , Wang CJ, Gnosa S, Wallin A, et al
    Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients.
    BMC Cancer. 2011;11:345.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ABULI A , Fernandez-Rozadilla C, Alonso-Espinaco V, Munoz J, et al
    Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.
    BMC Cancer. 2011;11:339.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
26. SONG KS , Li G, Kim JS, Jing K, et al
    Protein-bound polysaccharide from Phellinus linteus inhibits tumor growth, invasion, and angiogenesis and alters Wnt/beta-catenin in SW480 human colon cancer cells.
    BMC Cancer. 2011;11:307.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. TSE VC , Ng WT, Lee V, Lee AW, et al
    Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement.
    BMC Cancer. 2011;11:288.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. PORQUET N , Poirier A, Houle F, Pin AL, et al
    Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFkappaB survival axis downstream of Death Receptor-3.
    BMC Cancer. 2011;11:285.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
29. CHAUVENET M , Cottet V, Lepage C, Jooste V, et al
    Trends in colorectal cancer incidence: a period and birth-cohort analysis in a well-defined French population.
    BMC Cancer. 2011;11:282.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. KIM YG , Baek JY, Kim SY, Lee DH, et al
    Peritoneal lymphomatosis confounded by prior history of colon cancer: a case report.
    BMC Cancer. 2011;11:276.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LOUPAKIS F , Ruzzo A, Salvatore L, Cremolini C, et al
    Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.
    BMC Cancer. 2011;11:247.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. GUSTAFSSON ASTING A , Caren H, Andersson M, Lonnroth C, et al
    COX-2 Gene Expression in Colon Cancer Tissue related to Regulating Factors and Promoter Methylation Status.
    BMC Cancer. 2011;11:238.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. QI W , Weber CR, Wasland K, Savkovic SD, et al
    Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
    BMC Cancer. 2011;11:219.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
34. WU CC , Tsai FM, Shyu RY, Tsai YM, et al
    G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells.
    BMC Cancer. 2011;11:175.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
35. REYES-ZURITA FJ , Pachon-Pena G, Lizarraga D, Rufino-Palomares EE, et al
    The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism.
    BMC Cancer. 2011;11:154.
    PubMed     Text format     Related articles   
    
    
    
    
36. LALIER L , Pedelaborde F, Braud C, Menanteau J, et al
    Increase in intracellular PGE2 induces apoptosis in Bax-expressing colon cancer cells.
    BMC Cancer. 2011;11:153.
    PubMed     Text format     Related articles   
    
    
    
    
37. NAGUIB A , Cooke JC, Happerfield L, Kerr L, et al
    Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors.
    BMC Cancer. 2011;11:123.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
38. SPINDLER KL , Niels P, Jan L, Sanne FK, et al
    EGFR Related Mutational Status and Association to Clinical Outcome of Third-line Cetuximab-Irinotecan in Metastatic Colorectal Cancer.
    BMC Cancer. 2011;11:107.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. LOOF J , Rosell J, Bratthall C, Dore S, et al
    Impact of PINCH expression on survival in colorectal cancer patients.
    BMC Cancer. 2011;11:103.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
40. HABANO W , Gamo T, Terashima J, Sugai T, et al
    Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.
    BMC Cancer. 2011;11:81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. ABE M , Havre PA, Urasaki Y, Ohnuma K, et al
    Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines.
    BMC Cancer. 2011;11:51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
42. KITAYAMA J , Yasuda K, Kawai K, Sunami E, et al
    Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.
    BMC Cancer. 2011;11:64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. LEE MS , Hsu CC, Wahlqvist ML, Tsai HN, et al
    Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
    BMC Cancer. 2011;11:20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CELLIER P , Leduc B, Martin L, Vie B, et al
    Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.
    BMC Cancer. 2011;11:98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ZHANG ZY , Zhang H, Adell G, Sun XF, et al
    Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy.
    BMC Cancer. 2011;11:89.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. BORNHOLDT J , Friis S, Godiksen S, Poulsen SS, et al
    The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.
    BMC Cancer. 2011;11:65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ZAMPINO MG , Magni E, Leonardi MC, Santoro L, et al
    Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma.
    BMC Cancer. 2011;11:55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. VAN GEELEN CM , Pennarun B, Le PT, de Vries EG, et al
    Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.
    BMC Cancer. 2011;11:39.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. FANG Z , Yao W, Xiong Y, Li J, et al
    Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.
    BMC Cancer. 2011;11:195:1-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. FUJII T , Tabe Y, Yajima R, Yamaguchi S, et al
    Process of distant lymph node metastasis in colorectal carcinoma: implication of extracapsular invasion of lymph node metastasis.
    BMC Cancer. 2011;11:216.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LI Q , Wang D, Li J, Chen P, et al
    Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas.
    BMC Cancer. 2011;11:277.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. AGER EI , Wen SW, Chan J, Chong WW, et al
    Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    BMC Cancer. 2011;11:11:274.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. OORT FA , van Turenhout ST, Coupe VM, van der Hulst RW, et al
    Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.
    BMC Cancer. 2011;11:434.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. MULLER KM , Tveteraas IH, Aasrum M, Odegard J, et al
    Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
    BMC Cancer. 2011;11:421.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. RADHAKRISHNAN VM , Putnam CW, Qi W, Martinez JD, et al
    P53 suppresses expression of the 14-3-3 gamma oncogene.
    BMC Cancer. 2011;11:378.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
56. MEYNERS T , Heisterkamp C, Kueter JD, Veninga T, et al
    Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis.
    BMC Cancer. 2010;10:582.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
57. MLADKOVA J , Sanda M, Matouskova E, Selicharova I, et al
    Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.
    BMC Cancer. 2010;10:449.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. FANG H , Shen L, Chen T, He J, et al
    Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer.
    BMC Cancer. 2010;10:421.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
59. HILL A , Bergin P, Hanning F, Thompson P, et al
    Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
    BMC Cancer. 2010;10:451.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. JI X , Tang J, Halberg R, Busam D, et al
    Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study.
    BMC Cancer. 2010;10:426.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. SCHEEL SK , Porzner M, Pfeiffer S, Ormanns S, et al
    Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.
    BMC Cancer. 2010;10:413.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. LOPEZ-VILLAR I , Ayala R, Wesselink J, Morillas JD, et al
    Simplifying the detection of MUTYH mutations by high resolution melting analysis.
    BMC Cancer. 2010;10:408.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. WANG Y , Gong C, Yang L, Wu Q, et al
    5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.
    BMC Cancer. 2010;10:402.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. KWON HK , Hwang JS, So JS, Lee CG, et al
    Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1.
    BMC Cancer. 2010;10:392.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. FOSTIRA F , Thodi G, Sandaltzopoulos R, Fountzilas G, et al
    Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients.
    BMC Cancer. 2010;10:389.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. AULINO P , Berardi E, Cardillo VM, Rizzuto E, et al
    Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
    BMC Cancer. 2010;10:363.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. LINNEBACHER M , Maletzki C, Ostwald C, Klier U, et al
    Cryopreservation of human colorectal carcinomas prior to xenografting.
    BMC Cancer. 2010;10:362.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. STRUMPF EC , Chai Z, Kadiyala S
    Adherence to cancer screening guidelines across Canadian provinces: an observational study.
    BMC Cancer. 2010;10:304.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. RADEVA MY , Jahns F, Wilhelm A, Glei M, et al
    Defensin alpha 6 (DEFA 6) overexpression threshold of over 60 fold can distinguish between adenoma and fully blown colon carcinoma in individual patients.
    BMC Cancer. 2010;10:588.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. PINHEIRO M , Ahlquist T, Danielsen SA, Lind GE, et al
    Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.
    BMC Cancer. 2010;10:587.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. LEE CK , Lee JH, Lee MG, Jeong SI, et al
    Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.
    BMC Cancer. 2010;10:577.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. ROMAIN B , Neuville A, Meyer N, Brigand C, et al
    Allelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment.
    BMC Cancer. 2010;10:561.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. THODI G , Fostira F, Sandaltzopoulos R, Nasioulas G, et al
    Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.
    BMC Cancer. 2010;10:544.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. MOLAEI M , Mansoori BK, Mashayekhi R, Vahedi M, et al
    Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?
    BMC Cancer. 2010;10:537.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. PELZ JO , Chua TC, Esquivel J, Stojadinovic A, et al
    Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.
    BMC Cancer. 2010;10:689.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. HEMMINKI K , Santi I, Weires M, Thomsen H, et al
    Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes.
    BMC Cancer. 2010;10:688.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. PATTEN SG , Adamcic U, Lacombe K, Minhas K, et al
    VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment.
    BMC Cancer. 2010;10:683.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. VAN WAART H , Stuiver MM, van Harten WH, Sonke GS, et al
    Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue.
    BMC Cancer. 2010;10:673.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. SUNDSTROM M , Edlund K, Lindell M, Glimelius B, et al
    KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.
    BMC Cancer. 2010;10:660.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: